Representative before the EPO

Employment test 11 - 50 employees
Company dna elkington and fife llp
operating since 1927
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

Richard Edward Gillard has worked on the following 41 EPO patent applications which have been published in the last five years:

EP11840795

ALUMINA CATALYST SUPPORT

IPC classification:
B01J 21/12
Applicant:
Rhodia Operations SAS
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP11842211

SULFUR TOLERANT ALUMINA CATALYST SUPPORT

IPC classification:
B01J 21/12
Applicant:
Rhodia Operations SAS
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP12718318

A DEVICE FOR DETECTING AN ANALYTE

IPC classification:
G01N 21/17, G01N 29/24, G01N 33/542, G01N 33/543
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
PATENT GRANTED
EP11865208

METHOD FOR TREATING PROSTATE CANCER

IPC classification:
A61K 36/00
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11839738

AGRICULTURAL PESTICIDE COMPOSITIONS

IPC classification:
A01N 25/02, A01N 25/04, A01N 37/34, A01N 43/653, A01N 47/36, A01N 53/08, A01N 57/20, A01N 59/20, A01P 3/00, A01P 7/00, A01P 13/00
Applicant:
Rhodia Operations SAS
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP12817817

CYSTEINE PRODRUGS

IPC classification:
A61K 31/426, A61P 25/00, C07D 277/14
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP12823540

SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE) BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIITORS

IPC classification:
A01N 37/36, C07C 241/00, C07C 243/00
Applicant:
University of Utah Research Foundation
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP13003519

Novel polymorphic forms of perindopril (L)-arginine and process for the preparation thereof

IPC classification:
A61K 31/404, A61P 9/12, C07D 209/42
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
Alexander Wittkopp, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP12853818

SINGLE MODE MICROWAVE DEVICE FOR PRODUCING EXFOLIATED GRAPHITE

IPC classification:
B01J 19/12, C01B 31/04
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
PATENT GRANTED
EP12810409

METHOD AND DEVICE FOR MEASURING COAGULATION IN A SAMPLE OF A BLOOD PRODUCT

IPC classification:
B01L 3/00, B82Y 15/00, G01N 15/05, G01N 21/17, G01N 21/82, G01N 25/48, G01N 29/02, G01N 29/24, G01N 33/49, G01N 33/86
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12806382

AN INHALABLE MEDICAMENT COMPRISING TIOTROPIUM

IPC classification:
A61K 9/00, A61K 9/12, A61K 31/46, A61P 11/00
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
David William Cottam, Teva Global Patent Group
Status:
PATENT GRANTED
EP12805442

AN INHALER COMPRISING A TIOTROPIUM-CONTAINING-COMPOSITION

IPC classification:
A61K 9/12, A61K 31/46, A61P 11/00
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
David William Cottam, Teva UK Ltd.
Agent:
David William Cottam, Teva Global Patent Group
Status:
GRANT OF PATENT INTENDED
EP12779275

TRANSDERMAL COMPOSITIONS OF IBUPROFEN AND METHODS OF USE THEREOF

IPC classification:
A61K 31/192, A61K 47/10, A61K 47/14, A61K 47/18, A61K 47/20, A61K 47/22, A61K 47/38, A61P 29/00
Agent:
Multiple attorneys, Fish & Richardson PC
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP12766194

COMPOSITIONS AND METHODS FOR TREATMENT OF GLAUCOMA

IPC classification:
A61K 9/00, A61K 47/10
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
APPLICATION WITHDRAWN
EP13746990

BLAST TREATMENT METHOD

IPC classification:
B21J 5/06, B30B 5/00, F42B 33/06, F42D 5/04
Applicant:
Kabushiki Kaisha Kobe Seiko Sho (Kobe Steel Ltd)
Agent:
Multiple attorneys, Elkington and Fife LLP
Status:
PATENT GRANTED
EP13726306

AN IMPROVED PROCESS FOR THE PREPARATION OF ALISKIREN

IPC classification:
C07C 231/12, C07C 231/22
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14158985

Amorphous rotigotine transdermal system

IPC classification:
A61K 9/70, A61K 31/381
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
Christopher K. Hamer, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13718030

AN ASSAY LABEL

IPC classification:
G01N 33/543, G01N 33/548, G01N 33/58
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11772354

EXPANDABLE ELASTOMERIC MATERIAL IN THE PRESENCE OF WATER OR OIL

IPC classification:
C08F 2/32, C08F 220/56, C08L 33/26, C08L 75/14, C08L 83/04, C09K 8/28
Applicant:
Rhodia Operations SAS
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP14809248

AN INHALABLE MEDICAMENT

IPC classification:
A61K 9/00
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP14809570

AN INHALABLE MEDICAMENT

IPC classification:
A61K 9/00
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP13844898

COMBINATION DRUG COMPRISING GEMIGLIPTIN AND METFORMIN, AND METHOD FOR THE PREPARATION THEREOF

IPC classification:
A61K 9/20, A61K 9/24, A61K 31/155
Applicant:
LG Chem Ltd
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP13852301

THIOARYL DERIVATIVES AS GPR120 AGONISTS

IPC classification:
A61K 31/44, A61P 3/10, C07D 213/80, C07D 241/18
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP13852767

GPR40 RECEPTOR AGONIST, METHODS OF PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT

IPC classification:
A61K 31/404, A61P 3/10, C07D 209/22, C07D 409/04
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP13859129

AUTOMATIC IN VITRO DIAGNOSTIC APPARATUS INCLUDING INCLINED ROTATING PLATE

IPC classification:
G01N 21/78, G01N 33/52, G01N 33/53, G01N 37/00
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP15161261

PROPIONIC ACIDS, PROPIONIC ACID ESTERS, AND RELATED COMPOUNDS

IPC classification:
A61K 31/195, A61P 25/18, C07C 323/57, C07D 211/80, C07D 309/02
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
PATENT GRANTED
EP14746632

PPAR AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS

IPC classification:
A61K 31/47, A61P 25/00
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP14778370

MICRONIZED PHARMACEUTICAL COMPOSITIONS

IPC classification:
A61K 9/14
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
Hoffmann Eitle PartmbB
Status:
EXAMINATION REQUESTED
EP14764870

COMPLEX PREPARATION INCLUDING VALSARTAN AND ROSUVASTATIN CALCIUM AND MANUFACTURING METHOD THEREFOR

IPC classification:
A61K 31/41, A61K 31/505, A61P 3/00, A61P 3/06
Applicant:
LG Chem Ltd
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP14791773

INTERMEDIATE CONNECTOR

IPC classification:
B29C 45/76
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP12196725

An inhalable medicament comprising tiotropium

IPC classification:
A61K 9/00, A61K 9/12, A61K 31/46, A61P 11/00
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
David William Cottam, Teva UK Ltd.
Status:
PATENT GRANTED
EP13151885

Method of protecting teeth against erosion

IPC classification:
A23G 4/06, A23G 4/08, A61K 8/19, A61K 8/21, A61K 8/24, A61K 8/81, A61Q 11/00
Applicant:
The Procter & Gamble Company
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
Uta Susanne Joos, Braun GmbH
Status:
PATENT GRANTED
EP14831578

PROCESS FOR PRODUCING WATER-ABSORBING RESIN PARTICLE

IPC classification:
C08F 2/32, C08F 20/00, C08K 5/10, C08L 101/14
Applicant:
Sumitomo Seika Chemicals Co., Ltd.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP11716396

CHITOSAN COMPOSITION

IPC classification:
A61K 9/06, A61K 31/337, A61K 31/4439, A61K 31/58, A61K 31/593, A61K 47/36, C08L 5/08
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13176697

Method for forming semipermeable membranes for sensor applications using photopolymerizable silicone materials

IPC classification:
G01N 27/40, G01N 33/543, G03F 7/075
Applicant:
Dow Corning Corporation
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12196726

AN INHALER COMPRISING A TIOTROPIUM-CONTAINING-COMPOSITION

IPC classification:
A61K 9/00, A61K 9/12, A61K 31/46, A61K 47/10, A61K 47/12, A61M 11/04, A61M 15/00, A61P 11/08
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
David William Cottam, Teva UK Ltd.
Status:
PATENT GRANTED
EP13152263

Hydrophilized substrate and method for hydrophilizing a hydrophobic surface of a substrate

IPC classification:
B32B 9/04, B32B 27/30, C08G 65/335, C08J 7/04, D06M 13/288, D06M 15/333, D06M 15/53, D06M 15/667, D21H 17/10, D21H 27/30
Applicant:
Solvay USA Inc.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
PATENT GRANTED
EP11796916

INHALERS WITH HOUSING CAPS FOR INHALERS

IPC classification:
A61M 15/00
Applicant:
Teva Pharmaceutical Industries Ltd.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
David William Cottam, Teva UK Ltd.
Status:
PATENT GRANTED
EP15732545

AEROSOL DEVICE

IPC classification:
A61M 15/00, A61M 15/08
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP16185402

AN INHALABLE MEDICAMENT COMPRISING TIOTROPIUM

IPC classification:
A61K 9/00, A61K 9/12, A61K 31/46, A61K 47/10, A61K 47/12, A61M 15/00, A61P 11/00
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
APPLICATION PUBLISHED
EP15784372

PROCESS FOR PREPARING A POLYMORPH OF RIVAROXABAN

IPC classification:
C07D 413/14
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made

Please Sign in to use this feature